近１０多年来，贲门癌的手术切除率虽然有所提高，但术后的远期生存率却没有明显的改善，综合文献报告，术后５年生存率均未超过３０％〔１－３〕。我们开展了贲门癌根治术中同时进行大剂量抗癌药物经胃区域性动脉灌注的研究，经３～７年的随访观察，疗效满意，现报告如下... In the past 10 years, although the surgical resection rate of cardia cancer has been improved, the long-term survival rate after surgery has not been significantly improved. The comprehensive literature reports that the postoperative 5-year survival rate does not exceed 30% [1-3]. . We conducted a study of high-dose anticancer drug transgastric regional arterial infusion during cardia cancer radical surgery. After 3 to 7 years of follow-up observation, the efficacy was satisfactory. The report is as follows...